These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21410456)

  • 1. Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin?
    Kast RE; Karpel-Massler G; Halatsch ME
    Br J Pharmacol; 2011 Nov; 164(5):1393-6. PubMed ID: 21410456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.
    Zhang WB; Wang Z; Shu F; Jin YH; Liu HY; Wang QJ; Yang Y
    J Biol Chem; 2010 Dec; 285(52):40461-71. PubMed ID: 20880848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.
    Sesen J; Dahan P; Scotland SJ; Saland E; Dang VT; Lemarié A; Tyler BM; Brem H; Toulas C; Cohen-Jonathan Moyal E; Sarry JE; Skuli N
    PLoS One; 2015; 10(4):e0123721. PubMed ID: 25867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.
    Golubovskaya VM; Huang G; Ho B; Yemma M; Morrison CD; Lee J; Eliceiri BP; Cance WG
    Mol Cancer Ther; 2013 Feb; 12(2):162-72. PubMed ID: 23243059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.
    Karpel-Massler G; Kast RE; Westhoff MA; Dwucet A; Welscher N; Nonnenmacher L; Hlavac M; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
    J Neurooncol; 2015 Mar; 122(1):21-33. PubMed ID: 25524815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
    Carlson BL; Grogan PT; Mladek AC; Schroeder MA; Kitange GJ; Decker PA; Giannini C; Wu W; Ballman KA; James CD; Sarkaria JN
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):212-9. PubMed ID: 19695438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway.
    Yuan Y; Xue X; Guo RB; Sun XL; Hu G
    CNS Neurosci Ther; 2012 Jul; 18(7):536-46. PubMed ID: 22530672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
    Clarke JL; Iwamoto FM; Sul J; Panageas K; Lassman AB; DeAngelis LM; Hormigo A; Nolan CP; Gavrilovic I; Karimi S; Abrey LE
    J Clin Oncol; 2009 Aug; 27(23):3861-7. PubMed ID: 19506159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.
    Hegi ME; Diserens AC; Godard S; Dietrich PY; Regli L; Ostermann S; Otten P; Van Melle G; de Tribolet N; Stupp R
    Clin Cancer Res; 2004 Mar; 10(6):1871-4. PubMed ID: 15041700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to temozolomide in brain tumor initiating cells.
    Blough MD; Westgate MR; Beauchamp D; Kelly JJ; Stechishin O; Ramirez AL; Weiss S; Cairncross JG
    Neuro Oncol; 2010 Jul; 12(7):756-60. PubMed ID: 20388697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide (Temodar).
    Wesolowski JR; Rajdev P; Mukherji SK
    AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
    Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
    Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma.
    Hsieh SY; Chan DT; Kam MK; Loong HH; Tsang WK; Poon DM; Ng SC; Poon WS
    Hong Kong Med J; 2017 Dec; 23(6):594-8. PubMed ID: 28798282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells.
    Borges KS; Castro-Gamero AM; Moreno DA; da Silva Silveira V; Brassesco MS; de Paula Queiroz RG; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):405-14. PubMed ID: 22160182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
    Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes.
    Papachristodoulou A; Signorell RD; Werner B; Brambilla D; Luciani P; Cavusoglu M; Grandjean J; Silginer M; Rudin M; Martin E; Weller M; Roth P; Leroux JC
    J Control Release; 2019 Feb; 295():130-139. PubMed ID: 30537486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.